
è¶ å æŽŸã®æ³æ¡ã¯ãæ°å幎ã¶ãã®æå€§èŠæš¡ã®æ¹é©æšé²ãšããŠCOVIDã¯ã¯ãã³ã«ããè¢«å®³è«æ±ãVICPã«ç§»ãããš
å èšäºã¯ãã¡ããã/Click here to read the original article.
ç«ææ¥ã«æåºãããè¶ å æŽŸã®æ³æ¡ã¯ãå šåœã¯ã¯ãã³å·å®³è£åããã°ã©ã (VICP)ãææ¬çã«èŠçŽããæªè§£æ±ºã®COVID-19ã¯ã¯ãã³å·å®³è«æ±ãæ¹å€ã®å€ã察çå·å®³è£åããã°ã©ã ããVICPã«ç§»ãããšãèªãããã®ã§ããReact19ã¯ãã®ææ¡ããæ°å幎ã¶ãã«ãåœã®ã¯ã¯ãã³è¢«å®³è£åå¶åºŠã®å ¬å¹³æ§ãå埩ããããã®æãéèŠãªåãçµã¿ããšåŒã³ãŸããã
ç±³åœäžé¢è°å¡ãã¡ã¯ç«ææ¥ãå šåœã¯ã¯ãã³å·å®³è£åããã°ã©ã (VICP)ãå šé¢çã«èŠçŽãè¶ å æŽŸã®æ³æ¡ãæåºããCOVID-19ã¯ã¯ãã³ã«ããå·å®³è«æ±ããã®ããã°ã©ã ã«ç§»è¡ããããšãææ¡ããŸããã
ã¯ã¯ãã³å·å®³è£åè¿ä»£åæ³ã¯ã察çå·å®³è£åããã°ã©ã (CICP)ããã«ããŒãããCOVID-19ã¯ã¯ãã³å·å®³è«æ±ãVICPã«ç§»ç®¡ããŸãã
ãŸããè£åé床é¡ã®æŽæ°ãã¯ã¯ãã³é©çšã®æ¡å€§ãè«æ±ã倿ãã圹å¡ã®æ°ã®å¢å ãå«ãŸããŸãã
COVID-19ã¯ã¯ãã³ã«ãã£ãŠè¢«å®³ãåãã人ã ãæ¯æŽããéå¶å©å£äœReact19ã¯ããã®ææ¡ããã¢ã¡ãªã«ã®ã¯ã¯ãã³å·å®³è£åå¶åºŠã®å ¬å¹³æ§ãå埩ããããã®æ°å幎ã¶ãã®æãéèŠãªåãçµã¿ããšåŒã³ãŸããã
ãReact19ã®ã³ãã¥ããã£ã«ãšã£ãŠããã®æ³æ¡ã¯åãªãæ¿çææ¡ä»¥äžã®æå³ãæã€ããšåçµç¹ã¯è¿°ã¹ãŠããŸãããããã¯åžæã衚ããŠãããã
React19ã®å ±ååµèšè ããªã¢ã³ãã»ãã¬ãã»ã³ã¯ããã®æ³æ¡ã¯å¿ãããããšæããŠãã人ã ã®é·å¹Žã®æè·æŽ»åãåæ ããŠãããšè¿°ã¹ãŸããã
ã仿¥ã¯ãæªæãç¡èŠããªãã£ã人ã ã®é·å¹Žã®å·æãªæè·ã®é倧æã§ãããšãã¬ãã»ã³ã¯èªããŸãããããã®æ³æ¡ã¯éèŠãªã¡ãã»ãŒãžãéããŸãããã¹ãŠã®ã¢ã¡ãªã«äººã声ãäžããæš©å©ãããã®ã§ããã
äžé¢æ³å ¥å§å¡äŒã®ãã€ãã»ãã²ãã(æ°äž»å ã»ãããµã¹å·)ãšãã€ãã»ã¹ããã«ãŒ(å ±åå ã»ãã³ã·ã«ããã¢å·)ããã®æ³æ¡ãæåºããŸããã
ãä»ã誰ã§ãæªæããã人ãããã
é·å¹Žã¯ã¯ãã³å·å®³è£åã®æè·è ã§ãããVICPã«ã€ããŠå¹ åºãå·çããŠãããŠã§ã€ã³ã»ããŒãæ°ã¯ããã®æ³æ¡ãè°å¡ãã¡ããã¯ãç¡èŠã§ããªãåé¡ã«åãçµãã§ãããšè¿°ã¹ãŸããã
ãCOVIDã¯ã¯ãã³ã«ããæªæã«å¯ŸåŠããå¿ èŠãããããšããŒãã¯The Defenderã«èªã£ãããããã¢ã¡ãªã«ã§æå¹ãªã¯ã¯ãã³æ¿çãç¶æããè² å·è ã«è£åããªããã°ã次ã®ãã³ãããã¯ã§ã¯ãä»ã誰ããè² å·è ãç¥ã£ãŠããããã察çãåãå ¥ããåžæ°ãå®å šã«é¢ããŠããã§ããããã
åæã«ãããŒãæ°ã¯COVID-19ã¯ã¯ãã³ãVICPã«ç§»è¡ããããšã«æžå¿µããããšè¿°ã¹ãŸããããªããªãããã®æ³æ¡ãé¡äŒŒã®mRNAæè¡ã§éçºããã远å ã®ã¯ã¯ãã³ãããã°ã©ã ã«æã¡èŸŒãå¯èœæ§ãããããã§ãã
ãéçºã«äœ¿ãããæè¡ã«ã€ããŠæžå¿µããããåŸæ¥ã®ã¯ã¯ãã³ã¡ãŒã«ãŒãåãæè¡ãããã°ã©ã 察象ã®ä»ã®ã¯ã¯ãã³ã«ã䜿ãããšã«ãªãã®ã§ã¯ãªãããšæžå¿µããŠããŸãããšåœŒã¯è¿°ã¹ãŸããã
ãŸãããã®æ³æ¡ã¯VICPã®é©çšç¯å²ãæäººã¯ã¯ãã³ã®è¿œå ã«ãæ¡å€§ãããšè¿°ã¹ãŸããã
ãããRSVã垯ç¶ç±ç¹ããã³ã°ç±ãå ããã°ã次ã®ã¯ã¯ãã³ãããã°ã©ã ã«çµã¿èŸŒãŸããã ããããšããŒãæ°ã¯èªã£ãã
çŸåšãVICPã¯çŸç 察çã»ã³ã¿ãŒ(CDC)ãåã©ããåŠå©Šãžã®å®æçãªæ¥çš®ãæšå¥šããã¯ã¯ãã³ã®ã¿ã察象ãšããŠããŸãã
åã©ãå¥åº·é²è¡(CHD)ã®æ³åé¡§åãã ã»ããã¯ã»ããŒãŒã³ããŒã°æ°ã¯ãCHDã¯ãã®æ³æ¡ãæ¯æããŠããããããã€ãã®æžå¿µãæ±ããŠãããšè¿°ã¹ãã
ãç¹ã«COVID泚å°ã§è² å·ãã人ã ã«ãšã£ãŠã¯ã確ãã«æ£ããæ¹åãžã®äžæ©ã§ããããããVICPã¯å€ãã®ç¹ã§CICPããã¯ããã«åªããŠãããã®ã®ãã¯ã¯ãã³ã«ãã被害è ã«ãšã£ãŠã¯äŸç¶ãšããŠå®ç§ãªè§£æ±ºçã§ã¯ãããŸãããç§ãã¡ã¯åŒãç¶ããVICPã®å€æŽãç¹ã«è£å€æãžã®ã¢ã¯ã»ã¹ã®æ¡å€§ãæšé²ããŠãããŸããã
æ ¹æ¬çãªåé¡ã¯ãè£œé æ¥è ã1986幎ã®å šåœå ç«¥ã¯ã¯ãã³å·å®³æ³ããæ³çãªä¿è·ãåããŠãããããã責任ããä¿è·ãããå®å šãªã¯ã¯ãã³éçºã劚ããŠããç¹ã ãšããã¯ã»ããŒãŒã³ããŒã°æ°ã¯è¿°ã¹ãŸããã
ãã®æ³æ¡ã¯ç³è«æéãå»¶é·ããå ±é ¬äžéãåŒãäžããŸã
1986幎ã«èšç«ãããVICPã¯ãåŸæ¥ã®èšŽèšã«ä»£ããç¡é倱ã®ä»£æ¿ææ®µã§ããããŸããªã¯ã¯ãã³é¢é£ã®å·å®³ãè² ã£ã人ã ã«è£åãæäŸããŸãã
ãã®æ³æ¡ã¯ä»¥äžã®å 容ãå«ã¿ãŸãã
CICPããVICPãžã®COVID-19ã¯ã¯ãã³å·å®³è«æ±ã®ç§»ç®¡ãã«ããŒãããŸããã
ã¯ã¯ãã³ã«ããå·å®³è«æ±ã®ç³è«æéã3幎ãã5幎ã«å»¶é·ããŸãã
çã¿ãèŠãã¿ãæ»äº¡ã«å¯Ÿããè£åã®äžéã25äžãã«ãã60äžãã«ã«åŒãäžããå°æ¥çãªã€ã³ãã¬èª¿æŽãé©çšããŸãã
ç¹å¥ãã¹ã¿ãŒå¯©çè«æ±ã®æäœä»¶æ°ã8ä»¶ãã10ä»¶ã«å¢ããã
VICPã®é©çšç¯å²ãCOVID-19ãRSVã垯ç¶ç±ç¹ããã³ã°ç±ã¯ã¯ãã³ã«å ããCDCãæäººã«æšå¥šããä»ã®ã¯ã¯ãã³ãå«ããŸãããã
ãã²ããæ°ã¯ããã®æ³æ¡ã¯ãé
å»¶ã®å»¶é·ãè£åäžéã®æä»£é
ããCOVID-19ã¯ã¯ãã³ã®ã«ããŒæªçŽå
¥ãã«å¯ŸåŠãããã®ã ãšè¿°ã¹ãŸãããã¹ããã«ãŒæ°ã¯ããŸããªã¯ã¯ãã³ã«ããè² å·ãçµéšããã¢ã¡ãªã«äººã¯ãå
¬æ£ã§éæãã€å¹ççãªè£åå¶åºŠããåããã«å€ãããšè¿°ã¹ãŸããã
7æ1æ¥æç¹ã§è£åãããCOVIDã¯ã¯ãã³å·å®³è«æ±ã¯ããã62ä»¶ã§ã
COVID-19ã¯ã¯ãã³ã«ããå·å®³è«æ±ã¯ãã»ãšãã©ã®éåžžã®ã¯ã¯ãã³ã«é¢ããè«æ±ãšã¯ç°ãªãçµç·¯ããã©ã£ãŠããŸãã
ã¯ã¯ãã³ã¯æ°åã³ãããŠã€ã«ã¹ã®ãã³ãããã¯äžã«æåã«å°å ¥ããããããè«æ±ã¯VICPã§ã¯ãªãCICPã«åãããŸããã
CICPã¯ãå ¬è¡è¡çç·æ¥äºæ æã®ã»ãšãã©ã®èšŽèšããã¯ã¯ãã³ã¡ãŒã«ãŒãå»çæäŸè ãã«ããŒå¯Ÿè±¡ã®å¯Ÿçãæœè¡ãããã®ä»ã®äººã ãä¿è·ããå ¬å ±æºåã»ç·æ¥æºåæ³(Prep Act)ã«åºã¥ãèšç«ãããŸããã
ãã®çµæãCOVID-19ã¯ã¯ãã³ã«ããå·å®³ã蚎ãã人ã¯ãåŸæ¥ã®è£å€æã§èšŽèšãèµ·ããããšã¯ã§ããã代ããã«CICPãéããŠè£åãæ±ããªããã°ãªããŸãããCICPã§ã¯ãè² å·ãã1幎以å ã«è«æ±ãè¡ãå¿ èŠããããŸãã
VICPãšã¯ç°ãªããCICPã¯åžæ³å¯©æ»ãè¡ãããè£åã¯ä¿éºã§ã«ããŒãããªãå»çè²»ã倱ãããè³éã«éå®ããŠããŸãã
ãã®ããã°ã©ã ã¯ãCOVID-19ã«é¢ããè£åè«æ±ä»¶æ°ãæ¯èŒçå°ãªãããæ¹å€ãåããŠããŸãã
é£éŠããŒã¿ã«ãããšããã³ãããã¯éå§ä»¥æ¥ãCICPã«å¯ŸããŠ14,755ä»¶ã®COVID-19ã¯ã¯ãã³å·å®³è«æ±ãæåºãããŠããŸãã7æ1æ¥æç¹ã§ãè£åãããè«æ±ã¯ããã62ä»¶ã§ãç·é¡ã¯700äžãã«ãè¶ ããŠããŸãããæ°åä»¶ã®è«æ±ãä¿çäžãŸãã¯åŽäžãããŠããŸããã
ã¯ã¯ãã³è£åããã°ã©ã ã®æ¹åã¯ãè€éã§å°é£ãªæŠãããšãªã£ãŠããŸãã
CHDã®äžçŽå€éšé¡§ååŒè·å£«ã¬ã€ã»ãããŒã¬ã¹æ°ã¯ããã®æ³æ¡ã¯é£éŠã®å ±é ¬å¶åºŠã«æå³ã®ããå€åãããããããäžã€ã®è©Šã¿ã§ãããšè¿°ã¹ãŸããã
ããããŸã§ã¯ã¯ãã³è£åã®å®è³ªçãªå€æŽãå®çŸããããšã¯ãè€éã§å°é£ãªæŠãã§ããããšãããŒã¬ã¹ã¯The Defenderã«èªããŸããã
ãããŒã¬ã¹æ°ã¯ãCOVID-19ã¯ã¯ãã³ã«ããå·å®³ããäºã€ã®ç°ãªãé£éŠè£åå¶åºŠã«ãŸããã£ãŠãããããç¬èªã®æ³ç課é¡ãçãã§ãããšè¿°ã¹ãŸããã
圌ã¯ãææ¡ãããæ³æ¡ã¯COVID-19ã¯ã¯ãã³ã«ããå·å®³è«æ±ãVICPã«ç§»ãããšãç®æããŠããäžæ¹ã§ãç±³åœä¿å¥çŠç¥ç(HHS)ã¯åæã«ãCOVID-19ã¯ã¯ãã³ãVICPã®ã¯ã¯ãã³å·å®³ããŒãã«ã«è¿œå ãã矩åããã£ããã©ãããããã£ãŠæ³çäºãã«çŽé¢ããŠãããšè¿°ã¹ãŸããã
蚎èšã¯ãåœå®¶å°å ã¯ã¯ãã³å·å®³æ³ã®äžã§ãHHSãåã©ããžã®æ¥åžžäœ¿çšãæšå¥šãããCOVID-19ã¯ã¯ãã³ãæ€èšå¯Ÿè±¡ã«å ãã矩åããã£ããšäž»åŒµããŠããŸããããããæ©é¢ã¯ãããè¡ãããäžéšã®è² å·è ã¯VICPãéããŠè£åãæ±ããããšãã§ããªããªããŸããã
ããã«ãææ¡ãããæ³æ¡ã§ã¯COVID-19ã¯ã¯ãã³ã«ããå·å®³è«æ±ãVICPã«ç§»ããã®ã®ãHHSã¯å¥éCICPã匷åããæªçœ®ãè¬ããŠããŸãã
仿åããç±³åœä¿å¥é·å®ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢ã¯ãHHSãPREPæ³ã«åºã¥ãæ£åŒãªCOVID-19ã¯ã¯ãã³å·å®³ããŒãã«ã11æã«èšçœ®ããããã®èŠåå¶å®ããã»ã¹ãéå§ããèšç»ãçºè¡šããŸããã
ãã®è¡šã¯ãã説åŸåããããä¿¡é Œã§ãããæå¹ã§ãå»åŠçãã€ç§åŠç蚌æ ããšè£ä»ããããå Žåã察象ãšãªãCOVID-19ã¯ã¯ãã³ã«ããæšå®å·å®³ãç¹å®ããäžéšã®è«æ±è ãè£åãåããããããŸãã
ã±ããã£ã®çºè¡šã¯ãCICPã®ããŸããŸãªåŽé¢ã«ç°è°ãå±ããè€æ°ã®èšŽèšã®åŸã«è¡ãããã
ãã蚎èšã¯ãPREPæ³ã«åºã¥ãå·å®³è¡šã®äœæãHHSã«æ±ããŠããŸãããŸããCOVID-19ã¯ã¯ãã³ã§è² å·ãã人ã ã«ã¯è£åããã°ã©ã 以å€ã«å®è³ªçãªæ³çææžããªãããããã®ããã°ã©ã ã¯æ²æ³äžã®é©æ£æç¶ãã®ä¿è·ã«éåãããšäž»åŒµãã人ãããŸãã
ãäœäžäººãã®äººã ã...è«æ±ã®æåº
ããŒãæ°ã¯ãCOVID-19è«æ±ãVICPã«ç§»ç®¡ãããå Žåã®è²¡æ¿ç圱é¿ã«ãè°äŒã¯åããã¹ãã ãšè¿°ã¹ãŸããã
VICPã¯1988幎ã«éå¶ãéå§ããŠä»¥æ¥ã3äžä»¶ä»¥äžã®è«é¡ãæåºãããŠããŸãããCOVIDã¯ãããå§åããã ããããšããŒãã¯èªã£ãããäœäžäººãã®äººãçªç¶çŸããŠè«æ±ãç³ãç«ãŠãã§ããããã
ãã®æ³æ¡ã¯ã¯ã¯ãã³ã®ç©åçšãæå1人ããã75ã»ã³ããã2.20ãã«ã«åŒãäžãããã®ã®ãããŒãæ°ã¯ä¿¡èšåºéã«è¿œå ã®æ¯æŽãå¿ èŠã«ãªããšèããŠããŸãã圌ã¯è°äŒãã5åãã«ãã10åãã«ãã®ã¹ã¿ãŒãã¢ããè³éãæäŸããæåãããçšéã3ãã«ãã4ãã«ã«åŒãäžããå¿ èŠããããããããªããšæšå®ããŸããã
ãã®æ³æ¡ãé²å±ãããã©ããã¯äžç¢ºãã§ãã
ããã®éã¯ä»¥åã«ãéã£ãŠããããšããŒãæ°ã¯è¿°ã¹ãç¹å¥ãã¹ã¿ãŒã®æ°æ¡å€§ããã®ä»ã®æ¹åæ¡ãè°äŒã§åæ»ããŠããããšãææããã
ããã§ããè°å¡ãã¡ã¯COVID-19ã¯ã¯ãã³ã«ãã£ãŠè² å·ãã人ã ã®ããŒãºã«å¯Ÿå¿ããããå§åãé«ãŸã£ãŠãããšè¿°ã¹ãŸããã
ãè°äŒã¯ããã«èå³ããªãããšããŒãã¯èšã£ããããããã圌ãã¯æ¿æ²»çãªäœæ³¢ã«ãçŽé¢ããŠãããã€ãŸããç§ãã¡ã¯ãã®äººã ã®é¢åãèŠãªããã°ãªããªããã